title: Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors.
authors.affiliation: Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: S
authors.initials: S
authors.lastname: Fu
authors.affiliation: Juravinski Cancer Centre, Hamilton, ON, Canada.
authors.forename: H
authors.initials: H
authors.lastname: Hirte
authors.affiliation: London Health Sciences Centre, London, ON, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Welch
authors.affiliation: Soricimed Biopharma Inc., Moncton, NB, Canada.
authors.forename: T T
authors.initials: TT
authors.lastname: Ilenchuk
authors.affiliation: Soricimed Biopharma Inc., Moncton, NB, Canada.
authors.forename: T
authors.initials: T
authors.lastname: Lutes
authors.affiliation: Soricimed Biopharma Inc., Moncton, NB, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Rice
authors.affiliation: Sagecon Inc., Oakville, ON, Canada.
authors.forename: N
authors.initials: N
authors.lastname: Fields
authors.affiliation: CLINSIG Research Consulting Inc., Brampton, ON, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Nemet
authors.affiliation: Soricimed Biopharma Inc., Moncton, NB, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Dugourd
authors.affiliation: Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: S
authors.initials: S
authors.lastname: Piha-Paul
authors.affiliation: Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: V
authors.initials: V
authors.lastname: Subbiah
authors.affiliation: Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: L
authors.initials: L
authors.lastname: Liu
authors.affiliation: Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: J
authors.initials: J
authors.lastname: Gong
authors.affiliation: Department of Investigational Cancer Therapeutics, M. D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: D
authors.initials: D
authors.lastname: Hong
authors.affiliation: Soricimed Biopharma Inc., Moncton, NB, Canada. jstewart@soricimed.com.
authors.forename: J M
authors.initials: JM
authors.lastname: Stewart